Hypera S.A. (OTCMKTS:HYPMY) Short Interest Up 58.3% in February

Hypera S.A. (OTCMKTS:HYPMY - Get Free Report) was the recipient of a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 11,400 shares, a growth of 58.3% from the January 31st total of 7,200 shares. Based on an average daily trading volume, of 9,900 shares, the days-to-cover ratio is currently 1.2 days.

Hypera Trading Up 10.5 %

Shares of Hypera stock traded up $0.32 during trading on Wednesday, hitting $3.42. 56,707 shares of the company were exchanged, compared to its average volume of 8,293. The company has a debt-to-equity ratio of 0.68, a current ratio of 1.81 and a quick ratio of 1.41. The firm's fifty day moving average price is $3.16 and its 200 day moving average price is $3.90. Hypera has a 1-year low of $2.64 and a 1-year high of $6.99.

Hypera Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.